Loading clinical trials...
Loading clinical trials...
RATIONALE: 13 Cis retinoic acid may prevent the development of cancer cells. PURPOSE: Randomized double-blinded phase II trial to study the effectiveness of 13-cis retinoic acid with or without vitam...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Colorado, Denver
NCT06689488 · Lung Cancer
NCT00899405 · Lung Cancer
NCT07668037 · Non-Small Cell Carcinoma of Lung, Immunotherapy, and more
NCT06500481 · Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, and more
NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more
University of Colorado Cancer Center at University of Colorado Health Sciences Center
Denver, Colorado
National Jewish Center for Immunology and Respiratory Medicine
Denver, Colorado
Lung Cancer Institute
Denver, Colorado
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions